✓ International Shipping Available

OMI® PathDx

Metagenomic pathogen detection, powered by next-generation sequencing

OMI® PathDx
Detect 36,000+ Pathogens

One test, tens of thousands of possibilities

OMI® PathDx is built on metagenomics, allowing simultaneous detection of major microorganisms in a sample using next-generation sequencing — without needing to know in advance what you're looking for.

OMI® PathDx can detect more than 36,000 types of pathogens, including bacteria, fungi, viruses, and parasites, along with representative drug-resistance and virulence genes, without bias.

By using this test, the positive rate of pathogen diagnosis can be significantly increased — guiding targeted use of antibiotics and supporting precise diagnosis and treatment of infections.

What is tested?

A single OMI® PathDx panel screens across the following categories:

16,343

Bacteria

16,679

Viruses

2,431

Fungi

718

Parasites

281

Virulence Genes

Drug-Resistant Genes

Potential benefits

Detects infections missed by conventional testing Supports faster answers in complex cases Evaluates antimicrobial resistance markers concurrently Supports precision diagnosis and treatment Reduces the need for multiple tests Identifies pathogens without prior suspicion

Over 300,000 real samples

OMI® PathDx draws on data from over 300,000 real samples gathered across decades of lab-partner experience, forming a proprietary Detection Background Database of diversified pathogen and human metagenomic data for large-scale sample analysis.

Who can benefit?

Persons with chronic infection concerns Individuals with persistent infection symptoms without a diagnosis Patients with unexplained inflammatory or immune symptoms People with persistent symptoms despite negative standard test results Cases with persistent illness despite multiple treatments tried Complex cases requiring deeper investigation

Why choose OMI® PathDx?

Comprehensive testing

One-time detection of 36,000+ pathogens, including drug-resistant and virulence genes, for full-spectrum pathogen analysis in complex infections.

High data volume

Targeted sample pretreatment and optimized workflows enhance testing sensitivity, delivering accurate, reliable results for clinical decisions.

Precision processing

Unlike many laboratory tests that provide a result for a single moment in time, sequencing data remains valuable throughout life. Patients receive a comprehensive clinical report together with their variant data, creating a resource that can be revisited as genomic medicine advances.

Clinical-grade database

Powered by a clinical-grade database and intelligent algorithms to help ensure precise report outcomes that guide diagnosis and treatment of complex infections.

Reliable performance

Standardized quality management supports stable, consistent testing, validated through ongoing external quality assessments.

Resources

Demo Report Brochure Sample Collection Manual

Sample Information

Accepted sample types vary by clinical presentation. Contact us for guidance on which sample type is right for your case.

Turnaround Time

Results are typically available 12–14 working days from the date your sample reaches the lab.

International Availability

International shipping is available for this test. Contact our team for guidance specific to your country.

ISO 15189 Accredited ISO

ISO/IEC 27001 Accredited

Results from OMI® PathDx are not intended to be used as independent medical advice. Findings should be contextualized within the patient's broader clinical picture, and final treatment decisions rest with the patient and their treating physician. Always consult your physician regarding medication plans.

Not sure if this test is right for you?

Our team can help you decide whether OMI® PathDx fits your clinical picture.